Table 1.
Clinical characteristics (93 cases)
| Characteristic | No. (%) |
|---|---|
| Gender | |
| Male | 67(72.0) |
| Famale | 26(28.0) |
| Age (years) | |
| median(range) | 57(28–78) |
| <60 | 56(60.2) |
| ≥60 | 37(39.8) |
| Pathological type | |
| Squamous carcinoma | 27(29.0) |
| Adenocarcinoma | 58(62.4)9 |
| others | 8(8.6) |
| Karnofsky performance status | |
| ≤80 | 64(68.8) |
| >80 | 29(31.2) |
| T stage | |
| T1–2 | 32(34.4) |
| T3–4 | 61(65.6) |
| N stage | |
| N0–1 | 15(16.1) |
| N2–3 | 78(83.9) |
| Gross tumor volume (cm3) | |
| median(range) | 170(35.8-627.6) |
| <170 | 45(48.4) |
| ≥170 | 48(51.6) |
| Metastasis status | |
| Multiple organs | 37(39.8) |
| Brain | 15(16.1) |
| subcutaneous nodules | 2(2.2) |
| Distant lymph nodes | 5(5.4) |
| Lung | 21(22.6) |
| Bone | 24(25.8) |
| Liver | 5(5.4) |
| Adrenal | 5(5.4) |
| Single organ | 56(60.2) |
| Brain | 9(9.7) |
| subcutaneous nodules | 2(2.2) |
| Distant lymph nodes | 3(3.2) |
| Lung | 13(14.0) |
| Bone | 28(30.1) |
| Liver | 1(1.0) |
| Radiation dose(Gy) to primary tumor | |
| median(range) | 63(40–74) |
| <63 | 29(31.2) |
| ≥63 | 64(68.8) |
| Response of primary tumor | |
| Complete response | 5(5.4) |
| Partial response | 66(71.0) |
| Stable | 18(19.4) |
| Progressive | 4(4.3) |
| No. of chemotherapy cycle | |
| 4 | 89(95.7) |
| 5 | 4(4.3) |
| Radiotherapy to metastases | |
| Yes | 50((53.8) |
| No | 43(46.2) |